The Editorial Advisory Board of Pharma Focus Asia comprises of industry thought leaders with wide-ranging experience, expertise and significant contributions to the pharmaceutical industry. We thank and acknowledge our Editorial Advisory Board members' willingness to share their expertise and industry insights with us to offer our readers the most appropriate editorials covering issues of paramount importance to the industry.
A physician by education (MD) with training in business administration (MBA) and a seasoned professional he pioneered the introduction of pharmacovigilance as a subject and science in India in the year 2005. With his vision, he established the country’s first global pharmacovigilance unit in the country’s largest pharmaceutical company and scaled up several such organizations in this field in his career spanning 23 years. As the Senior VP of Global Delivery Excellence for Pharmacovigilance, Quality, and Regulatory Solutions, at EVERSANA a leading global organization servicing the pharma industry, he effectively manages diverse customers and drives strategic growth in the area of drugs, biologics, vaccines, and devices. His previous role as Global head of pharmacovigilance at SunPharma showcased his success in overseeing global pharmacovigilance functions, achieving cost savings, and ensuring compliance.
Brian D Smith is a world-recognised authority on the evolution of the life sciences industry. He welcomes comments and questions at email@example.com
Nigel has been a senior executive in pharmaceutical, biotech, and logistics, mainly working in global companies, and has over 25 years of experience in technical, managerial, and quality aspects of the life science industry, from APIs, cell cultures, to finished sterile products. He has worked with global companies such as AstraZeneca, MSD (Merck & Co), DHL Lifesciences, Roche, Johnson & Johnson, and Sanofi.
Quang Bui is currently the Chief Operation Officer for Anda Group, located in Hanoi, Vietnam. Quang has over ten years of experience in the Vietnamese pharmaceutical market and works as an expert consultant for GLG Research, Third Bridge, and VisaSQ, all of which specialise in the registration of pharmaceuticals, medical devices, supplements, and pharmaceutical regulatory affairs in the Vietnam market.
Gervasius is a partner based in Indonesia, with experience in market research and strategy consulting. His areas of expertise are in energy, oil and gas, telecommunications, and industrial products. He has managed several projects to support leading regional companies and large local firms across Indonesia, Malaysia, and the Philippines.
Tamara Miller has over 20 years of international clinical operations and product development experience and is currently Senior Vice President of Product Development at Actinogen Medical Australia. As part of the Actinogen team, Tamara oversees and manages the overall product development process and strategy including pre-clinical and clinical development, clinical operations, CMC & manufacturing, regulatory operations, and R&D budget/finance operations
Imelda Leslie Rillon has over twenty years of experience in quality management. Leslie is currently the Regional Quality Assurance Director for Zuellig Pharma, a leading healthcare services company in Asia. She is a key contributor to the development of Zuellig Pharma & Quality 4.0 roadmap and leads the team in ensuring the currency of the corporate Quality governance framework across the region by integrating digitalized quality processes for digitally enabled quality risk management.
Andri Kusandri, is Market Access and Government & Public Affairs Director of Merck Indonesia in the last 7 years. Having obtained his Bachelor Degree in Pharmacy at the Institut Teknologi Bandung (ITB), he has spent the last 20 years with predominantly international pharmaceutical companies with UCB Pharma, Johnson & Johnson, Pfizer and currently work at Merck Indonesia. Andri has much experience in the field of Marketing, Market Access, Pricing, Government Affairs and Public Policy.
Pharmaceutical, Biotechnology, and Healthcare: General Manager, Chief Quality Officer, Technical and Quality Director, Senior Quality Director, TQM Director, Professional and Expert Consultant, Proficient and Expert Trainer, Professional Lead Auditor, Expert Consultant @ MENA.
Nicoleta Grecu has over 13 years of experience in the pharmaceutical industry with a broad expertise in human medicinal products, combination products, biologics, and vaccines. She is currently the Director of Pharmacovigilance Clinical Quality Assurance at Clover Biopharmaceuticals, supporting the development of the pharmacovigilance program.